Argimon JM - Search Results

1

Argimon JM, Limon E, Vila J, Cabezas C. Argimon JM, et al. Alzheimer Dis Assoc Disord. 2005 Jan-Mar;19(1):41-4. doi: 10.1097/01.wad.0000160343.96562.8e. Alzheimer Dis Assoc Disord. 2005. PMID: 15764871

2

Health-related quality of life in carers of patients with dementia.

Argimon JM, Limon E, Vila J, Cabezas C. Argimon JM, et al. Fam Pract. 2004 Aug;21(4):454-7. doi: 10.1093/fampra/cmh418. Fam Pract. 2004. PMID: 15249537

3

[Commentary: Burden of care and quality of life in informal caregivers for disabled patients].

Argimon JM, Limón E, Abós T. Argimon JM, et al. Aten Primaria. 2003 Jun 30;32(2):84-5. doi: 10.1016/s0212-6567(03)70741-0. Aten Primaria. 2003. PMID: 12841993 Free PMC article. Spanish. No abstract available.

4

[CUIDA'L: a clinical trial evaluating the effectiveness of an intervention in care givers].

Vinyoles E, Copetti S, Cabezas C, Megido MJ, Espinàs J, Vila J, Montella N, Martínez A, Argimón JM; Grupo de Estudio CUIDA'L. Vinyoles E, et al. Among authors: argimon jm. Aten Primaria. 2001 Jan;27(1):49-53. doi: 10.1016/s0212-6567(01)78773-2. Aten Primaria. 2001. PMID: 11218976 Free PMC article. Spanish. No abstract available.

5

Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study.

Cabezas C, Coma E, Mora-Fernandez N, Li X, Martinez-Marcos M, Fina F, Fabregas M, Hermosilla E, Jover A, Contel JC, Lejardi Y, Enfedaque B, Argimon JM, Medina-Peralta M, Prieto-Alhambra D. Cabezas C, et al. Among authors: argimon jm. BMJ. 2021 Aug 18;374:n1868. doi: 10.1136/bmj.n1868. BMJ. 2021. PMID: 34407952 Free PMC article.

6

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2.

Hermosilla E, Coma E, Xie J, Feng S, Cabezas C, Méndez-Boo L, Fina F, Ballo E, Martínez M, Medina-Peralta M, Argimon JM, Prieto-Alhambra D. Hermosilla E, et al. Among authors: argimon jm. Nat Commun. 2022 Mar 23;13(1):1639. doi: 10.1038/s41467-022-29301-9. Nat Commun. 2022. PMID: 35322045 Free PMC article.

7

What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.

Reed C, Happich M, Argimon JM, Haro JM, Wimo A, Bruno G, Dodel R, Jones RW, Vellas B, Belger M. Reed C, et al. Among authors: argimon jm. J Alzheimers Dis. 2017;57(3):797-812. doi: 10.3233/JAD-160449. J Alzheimers Dis. 2017. PMID: 28304285 Free article.

8

Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study.

Olazarán J, Agüera-Ortiz L, Argimón JM, Reed C, Ciudad A, Andrade P, Dilla T. Olazarán J, et al. Among authors: argimon jm. Int Psychogeriatr. 2017 Dec;29(12):2081-2093. doi: 10.1017/S1041610217001211. Epub 2017 Jul 19. Int Psychogeriatr. 2017. PMID: 28720158

9

Frequency of health-care service use and severity of illness in undocumented migrants in Catalonia, Spain: a population-based, cross-sectional study.

Dalmau-Bueno A, García-Altés A, Vela E, Clèries M, Pérez CV, Argimon JM. Dalmau-Bueno A, et al. Among authors: argimon jm. Lancet Planet Health. 2021 May;5(5):e286-e296. doi: 10.1016/S2542-5196(21)00036-X. Lancet Planet Health. 2021. PMID: 33964238 Free article.

10

How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease?

Reed C, Barrett A, Lebrec J, Dodel R, Jones RW, Vellas B, Wimo A, Argimon JM, Bruno G, Haro JM. Reed C, et al. Among authors: argimon jm. Health Qual Life Outcomes. 2017 Jan 21;15(1):16. doi: 10.1186/s12955-017-0591-2. Health Qual Life Outcomes. 2017. PMID: 28109287 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page